Roche submits NDA

Roche (SWX:ROCZ) submitted an NDA to the FDA for marketing approval of its valganciclovir to treat cytomegalovirus (CMV) retinitis in AIDS patients. Valganciclovir is a prodrug of ROCZ's Cytovene ganc...